Tsubota Laboratory Incorporated (4890) AI Stock Analysis

• Market Cap: ¥9.34B
• Dividend Yield: N/A
• Average Volume (3M): 44.56K
• Price to Earnings (P/E): 52.7
• Beta (1Y): 0.60
• Revenue Growth: 101.17%
• EPS Growth: N/A
• Country: JP
• Employees: 7
• Sector: Healthcare
• Sector Strength: 48
• Industry: Medical - Pharmaceuticals
• EPS (TTM): -7.79
• Shares Outstanding: 25,794,300
• 10 Day Avg. Volume: 61,080
• 30 Day Avg. Volume: 44,560
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥386.00
• Price Target Upside: 6.63% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: ¥386.00 ▲(6.63% Upside)

The overall stock score is primarily influenced by strong financial performance, particularly in revenue growth and operational efficiency. However, technical analysis indicates bearish momentum, and valuation metrics suggest the stock is overvalued. The lack of dividend yield further impacts the valuation score.

Tsubota Laboratory Incorporated Business Overview & Revenue Model

Company Description

Tsubota Laboratory Incorporated (4890) is a Japanese company specializing in the development and manufacturing of precision measurement instruments and analytical solutions primarily for the medical and environmental sectors. The company focuses on innovative technologies that enhance the accuracy and efficiency of testing and analysis in various applications, including healthcare diagnostics and environmental monitoring. Tsubota Laboratory is committed to advancing scientific research and ensuring public safety through its high-quality products and services.

How the Company Makes Money

Tsubota Laboratory generates revenue through the sale of its precision measurement instruments and analytical solutions, which are used in medical diagnostics and environmental testing. The company has established key revenue streams from direct sales to hospitals, laboratories, and research institutions, as well as through partnerships with distributors that expand its market reach. Additionally, Tsubota Laboratory may engage in service contracts for maintenance and calibration of its instruments, providing ongoing revenue. Significant partnerships with healthcare providers and research organizations further enhance its earnings by facilitating the adoption of its technologies in critical applications.

Tsubota Laboratory Incorporated Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	1.29B	673.53M	954.69M	640.92M	687.50M	441.00M
Gross Profit	1.21B	20.53M	719.14M	557.02M	606.76M	277.00M
EBITDA	426.22M	-602.60M	184.19M	241.07M	271.61M	0.00
Net Income	397.92M	-641.32M	90.18M	153.32M	201.61M	3.00M
Balance Sheet
Total Assets	2.28B	2.30B	2.67B	1.62B	1.08B	530.00M
Cash, Cash Equivalents and Short-Term Investments	1.83B	1.88B	2.16B	1.17B	610.77M	380.00M
Total Debt	131.63M	116.90M	139.34M	223.82M	242.35M	60.00M
Total Liabilities	817.11M	927.93M	722.59M	873.44M	487.55M	-1.00K
Stockholders Equity	1.46B	1.37B	1.95B	744.35M	591.03M	330.00M
Cash Flow
Free Cash Flow	0.00	-313.35M	-20.27M	582.69M	-8.63M	258.50M
Operating Cash Flow	0.00	-301.35M	28.49M	654.91M	36.72M	262.84M
Investing Cash Flow	0.00	-12.00M	-54.03M	-72.23M	-43.60M	-4.41M
Financing Cash Flow	0.00	35.74M	1.01B	-18.53M	236.97M	18.58M

Tsubota Laboratory Incorporated Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 362.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4890, the sentiment is Neutral. The current price of 362 is below the 20-day moving average (MA) of 365.80, below the 50-day MA of 381.04, and below the 200-day MA of 399.79, indicating a neutral trend. The MACD of -4.21 indicates Negative momentum. The RSI at 48.48 is Neutral, neither overbought nor oversold. The STOCH value of 79.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4890.

Tsubota Laboratory Incorporated Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3417	75 Outperform	¥17.38B	6.07		2.09%	3.70%	37.00%
4350	71 Outperform	¥14.55B	12.04		2.51%	5.93%	-36.11%
3544	64 Neutral	¥11.64B	15.20		1.19%	4.87%	62.84%
2796	62 Neutral	¥5.87B	―		2.80%	16.60%	-19.16%
8095	60 Neutral	¥20.70B	8.67		3.52%	12.75%	-191.21%
4890	58 Neutral	¥9.34B	52.74		―	101.17%	―
Sector *	51 Neutral	$7.82B	-0.16	-39.78%	2.19%	21.38%	-1.56%

Tsubota Laboratory Incorporated Corporate Events

Tsubota Laboratory Reports Strong Financial Recovery in FY2025

Tsubota Laboratory, Inc. reported significant financial improvement for the fiscal year ended March 31, 2025, with net sales doubling and a return to profitability. This positive shift in financial performance underscores the company’s strengthened position in the industry, although the forecast for the next fiscal year indicates a slight decline in profits, suggesting potential challenges ahead.